Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects

<p>INTRODUCTION: Vaccines may be key components of a curative strategy for HIV-1. We investigated whether a novel immunogen, HIVconsv, designed to re-direct T cell responses to conserved viral epitopes, could impact the HIV-1 reservoir in chronic antiretroviral therapy (ART)-treated subjects w...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Hancock, G, Morón-López, S, Kopycinski, J, Puertas, M, Giannoulatou, E, Rose, A, Salgado, M, Hayton, E, Crook, A, Morgan, C, Angus, B, Chen, F, Yang, H, Martinez-Picado, J, Hanke, T, Dorrell, L
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	BioMed Central 2017

Những quyển sách tương tự

Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
Bằng: Ondondo, B, et al.
Được phát hành: (2013)

Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice
Bằng: Ondondo, B, et al.
Được phát hành: (2013)

Optimizing Delivery of the HIVconsv Immunogen in Rhesus Macaques
Bằng: Rosario, M, et al.
Được phát hành: (2011)

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
Bằng: Beatriz Mothe, et al.
Được phát hành: (2020-05-01)

HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02)
Bằng: Mothe, B, et al.
Được phát hành: (2020)

The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
Bằng: Ondondo, B, et al.
Được phát hành: (2013)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and ChAdV-63 in a phase I/IIa clinical trial
Bằng: Hanke, T, et al.
Được phát hành: (2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
Bằng: Borthwick, N, et al.
Được phát hành: (2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
Bằng: Borthwick NJ, et al.
Được phát hành: (2012-09-01)

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv
Bằng: Clutton, G, et al.
Được phát hành: (2013)

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
Bằng: Borthwick, N, et al.
Được phát hành: (2015)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
Bằng: Dorrell, L, et al.
Được phát hành: (2007)

Aiming for protective T-cell responses: A focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials
Bằng: Hanke, T
Được phát hành: (2019)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
Bằng: Moyo, N, et al.
Được phát hành: (2017)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
Bằng: Howles, S, et al.
Được phát hành: (2010)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
Bằng: Ahmed, T, et al.
Được phát hành: (2012)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
Bằng: Ahmed T, et al.
Được phát hành: (2012-09-01)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
Bằng: Naif Khalaf Alharbi
Được phát hành: (2019-01-01)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.
Bằng: Nathifa Moyo, et al.
Được phát hành: (2017-01-01)

MVA as a vector for vaccines against HIV-1.
Bằng: Im, E, et al.
Được phát hành: (2004)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
Bằng: Green, C, et al.
Được phát hành: (2015)

Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
Bằng: Lynette Siv Chea, et al.
Được phát hành: (2017-10-01)

Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
Bằng: Ramil R. Mintaev, et al.
Được phát hành: (2023-04-01)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
Bằng: Jakub Kopycinski, et al.
Được phát hành: (2023-10-01)

Parallel induction of CH505 B cell ontogeny-guided neutralizing antibodies and tHIVconsvX conserved mosaic-specific T cells against HIV-1
Bằng: Wee, E, et al.
Được phát hành: (2019)

Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
Bằng: Ondondo, B, et al.
Được phát hành: (2006)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Brookes, R, et al.
Được phát hành: (2008)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
Bằng: Naif Khalaf Alharbi, et al.
Được phát hành: (2022-08-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Roger H Brookes, et al.
Được phát hành: (2008-08-01)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
Bằng: Dieye, T, et al.
Được phát hành: (2013)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
Bằng: Tandakha N Dieye, et al.
Được phát hành: (2013-01-01)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
Bằng: Wyatt LS, et al.
Được phát hành: (2009-10-01)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
Bằng: Rowland-Jones Sarah L, et al.
Được phát hành: (2006-12-01)

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
Bằng: Bliss, C, et al.
Được phát hành: (2016)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
Bằng: Tandakha N. Dieye, et al.
Được phát hành: (2013-01-01)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
Được phát hành: (2013-01-01)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
Bằng: María Q. Marín, et al.
Được phát hành: (2020-08-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Được phát hành: (2011-01-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
Bằng: Roger H. Brookes, et al.
Được phát hành: (2011-01-01)

Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA
Bằng: David A. Matthews, et al.
Được phát hành: (2023-07-01)